down arrow

Torrent Pharma

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE685A01028
  • NSEID: TORNTPHARM
  • BSEID: 500420
INR
3,157.00
45.5 (1.46%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 3.12 lacs

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

3,127.053,187.60

52 Week

2,508.653,589.95
Valuation
Technical
Day's Volume

CASH

3.12 lacs (-28.60%) Volume

Shareholding (Dec 2024)

FII

16.17%

Held by 828 FIIs

DII

8.35%

Held by 30 DIIs

Promoter

68.31%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Poor long term growth as Net Sales has grown by an annual rate of 7.66% over the last 5 years

 
2

Stock is technically in a Bearish range

3

With ROCE of 29.6, it has a Very Expensive valuation with a 11.4 Enterprise value to Capital Employed

4

Reducing Promoter Confidence

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 106,842 Cr (Large Cap)

stock-summary
P/E

57.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

1.03%

stock-summary
Debt Equity

0.25

stock-summary
Return on Equity

23.19%

stock-summary
Price to Book

14.03

Revenue and Profits (1 Year):
Net Sales:
2,809 Cr
(Quarterly Results - Dec 2024)
Net Profit:
503 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (1.03%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-9.93%
0.79%
-9.14%
1 Year
22.46%
1.20%
23.66%
2 Years
102.72%
3.72%
106.44%
3 Years
125.96%
6.71%
132.67%
4 Years
145.36%
8.97%
154.33%
5 Years
147.1%
11.08%
158.18%

Latest dividend: 26 per share ex-dividend date: Jan-31-2025

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
7.66%
EBIT Growth (5y)
14.43%
EBIT to Interest (avg)
6.97
Debt to EBITDA (avg)
1.61
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.87
Tax Ratio
29.44%
Dividend Payout Ratio
57.21%
Pledged Shares
0
Institutional Holding
24.52%
ROCE (avg)
21.09%
ROE (avg)
21.25%
Valuation key factors
Factor
Value
P/E Ratio
57
Industry P/E
33
Price to Book Value
14.03
EV to EBIT
37.71
EV to EBITDA
29.45
EV to Capital Employed
11.41
EV to Sales
9.48
PEG Ratio
1.88
Dividend Yield
1.03%
ROCE (Latest)
29.63%
ROE (Latest)
23.19%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 35 Schemes (4.88%)

FIIs

Held by 828 FIIs (16.17%)

Promoter with highest holding

Torrent Investments Private Limited (68.31%)

Highest Public shareholder

Nps Trust (1.58%)

Individual Investors Holdings

4.61%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -2.77% vs 1.05% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 11.04% vs -0.88% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,809.00",
          "val2": "2,889.00",
          "chgp": "-2.77%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "914.00",
          "val2": "939.00",
          "chgp": "-2.66%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "57.00",
          "val2": "64.00",
          "chgp": "-10.94%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "503.00",
          "val2": "453.00",
          "chgp": "11.04%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "33.09%",
          "val2": "33.17%",
          "chgp": "-0.08%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 9.46% vs 13.22% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 19.11% vs 14.71% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "5,748.00",
          "val2": "5,251.00",
          "chgp": "9.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,843.00",
          "val2": "1,616.00",
          "chgp": "14.05%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "139.00",
          "val2": "194.00",
          "chgp": "-28.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "910.00",
          "val2": "764.00",
          "chgp": "19.11%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "32.64%",
          "val2": "31.22%",
          "chgp": "1.42%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 7.19% vs 11.98% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 17.07% vs 25.99% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "8,557.00",
          "val2": "7,983.00",
          "chgp": "7.19%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2,757.00",
          "val2": "2,485.00",
          "chgp": "10.95%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "196.00",
          "val2": "274.00",
          "chgp": "-28.47%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "88.00",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,413.00",
          "val2": "1,207.00",
          "chgp": "17.07%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "32.22%",
          "val2": "31.13%",
          "chgp": "1.09%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 11.52% vs 13.07% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 33.01% vs 60.23% in Mar 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "10,728.00",
          "val2": "9,620.00",
          "chgp": "11.52%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3,368.00",
          "val2": "2,842.00",
          "chgp": "18.51%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "354.00",
          "val2": "333.00",
          "chgp": "6.31%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "88.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,656.00",
          "val2": "1,245.00",
          "chgp": "33.01%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "31.89%",
          "val2": "30.03%",
          "chgp": "1.86%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
2,809.00
2,889.00
-2.77%
Operating Profit (PBDIT) excl Other Income
914.00
939.00
-2.66%
Interest
57.00
64.00
-10.94%
Exceptional Items
0.00
0.00
Consolidate Net Profit
503.00
453.00
11.04%
Operating Profit Margin (Excl OI)
33.09%
33.17%
-0.08%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is -2.77% vs 1.05% in Sep 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2024 is 11.04% vs -0.88% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
5,748.00
5,251.00
9.46%
Operating Profit (PBDIT) excl Other Income
1,843.00
1,616.00
14.05%
Interest
139.00
194.00
-28.35%
Exceptional Items
0.00
0.00
Consolidate Net Profit
910.00
764.00
19.11%
Operating Profit Margin (Excl OI)
32.64%
31.22%
1.42%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 9.46% vs 13.22% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is 19.11% vs 14.71% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
8,557.00
7,983.00
7.19%
Operating Profit (PBDIT) excl Other Income
2,757.00
2,485.00
10.95%
Interest
196.00
274.00
-28.47%
Exceptional Items
0.00
88.00
-100.00%
Consolidate Net Profit
1,413.00
1,207.00
17.07%
Operating Profit Margin (Excl OI)
32.22%
31.13%
1.09%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 7.19% vs 11.98% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is 17.07% vs 25.99% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
10,728.00
9,620.00
11.52%
Operating Profit (PBDIT) excl Other Income
3,368.00
2,842.00
18.51%
Interest
354.00
333.00
6.31%
Exceptional Items
88.00
0.00
Consolidate Net Profit
1,656.00
1,245.00
33.01%
Operating Profit Margin (Excl OI)
31.89%
30.03%
1.86%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 11.52% vs 13.07% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is 33.01% vs 60.23% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Torrent Pharmaceuticals Ltd. stock-summary
stock-summary
Torrent Pharmaceuticals Ltd.
Large Cap
Pharmaceuticals & Drugs
Torrent Pharmaceuticals Limited is a leading player in the Indian pharmaceutical sector, concentrating on the chronic and sub-chronic therapeutic segments. The Company has established itself as a leader in developing niche pharmaceutical solutions through its patient-centric innovation. The Company is a dominant player in the therapeutic areas of Cardiovascular (CV), Central Nervous System (CNS), Vitamins and Nutrients (VMN), Gastro-Intestinal (GI) and Anti-Diabetes (AD) therapies in India.
Company Coordinates stock-summary
Company Details
Torrent House, Off Ashram Road Ahmedabad Gujarat : 380009
stock-summary
Tel: 91-79-26599000
stock-summary
http://www.torrentpharma.com
stock-summary
investorservices@torrentpharma.com
Registrar Details
Karvy Computershare Pvt Ltd, Plot No 17-24 , Near Image Hospital,, Reliance Cybervilae,Vithalrao Nagar,, Madhapur, Hyderabad
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."